The antimicrobial susceptibility tester market is projected to grow from USD 4.4 billion in 2025 to USD 7.5 billion by 2035, at a CAGR of 5.6%. Clinical Diagnosis will dominate with a 49.6% market share, while automatic antimicrobial susceptibility testers will lead the equipment type segment with a 53.8% share.